Lei Du
Jiangsu Key Laboratory Of New Drug Research And Clinical Pharmacy
Xuzhou, 221004, China
Xuzhou, 221004, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 48 publications
Shikonin alleviates renal tubulointerstitial fibrosis in diabetic nephropathy via CCR5/ TGF-β1 signaling axis mediating EMT.
Journal: European journal of pharmacology
Published: July 01, 2025
Prrx1 promotes mesangial cell proliferation and kidney fibrosis through YAP in diabetic nephropathy.
Prrx1 promotes mesangial cell proliferation and kidney fibrosis through YAP in diabetic nephropathy.
Journal: Journal of pharmaceutical analysis
Published: November 07, 2024
GABP Promotes Mesangial Cell Proliferation and Renal Fibrosis Through GLI1 in Diabetic Nephropathy.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: July 03, 2024
LncRNA KIFAP3-5:1 inhibits epithelial-mesenchymal transition of renal tubular cell through PRRX1 in diabetic nephropathy.
Journal: Cell biology and toxicology
Published: January 14, 2024
16α-OHE1, a novel oestrogen metabolite, attenuates dysfunction of left ventricle contractility via regulation of autophagy after myocardial ischemia and reperfusion.
Journal: International journal of cardiology
Published: March 05, 2023
Inhibition of S100A8/A9 ameliorates renal interstitial fibrosis in diabetic nephropathy.
Journal: Metabolism: clinical and experimental
Published: September 28, 2022
Decreased Sirt3 contributes to cyclic production of reactive oxygen species and islet β-cell apoptosis in high glucose conditions.
Journal: Molecular biology reports
Published: May 24, 2022
Corrigendum to 'Targeting mammalian serine/threonine-protein kinase 4 through yes-associated protein/TEA domain transcription factor-mediated epithelial-mesenchymal transition ameliorates diabetic nephropathy orchestrated renal fibrosis [Metabolism Clinical and Experimental 108 (2020) 154258].
Journal: Metabolism: clinical and experimental
Published: March 15, 2022
Correction to: Novel biphenyl diester derivative AB-38b inhibits NLRP3 inflammasome through Nrf2 activation in diabetic nephropathy.
Journal: Cell biology and toxicology
Published: February 16, 2022
Author Correction: Inactivation of TSC1 promotes epithelial-mesenchymal transition of renal tubular epithelial cells in mouse diabetic nephropathy.
Journal: Acta pharmacologica Sinica
Published: October 14, 2021
Last Updated: 09/26/2026